Lymphaselect®

Lymphaselect®
Product Description

Indena SpA offers a wide range of pharmaceutical products which includes lymphaselect®. Botanical origin: melilotus officinalis (l.) pallas herb. Biological activity: lymphatic circulation improver. Contact us for more information.

Indena S.P.A

  • IT
  • 2015
    On CPHI since
  • 5
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Nutraceuticals
Specifications
  • Selling Points
    Assay: ?17.0% ?20.0% of coumarin by HPLC

Indena S.P.A

  • IT
  • 2015
    On CPHI since
  • 5
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Nutraceuticals

More Products from Indena S.P.A (41)

  • Galanthamine Bromidrate

    Product Galanthamine Bromidrate

    Glanthamine bromidrate. Botanical origin: narcissus pseudonarcissus l. bulb. Biological activity: anti-alzheimer. 
  • Ginkgo Biloba Eur. Ph.

    Product Ginkgo Biloba Eur. Ph.

    Indena SpA offers a wide range of pharmaceutical products which includes ginkgo biloba eur. ph. Botanical origin: ginkgo biloba l. leaf. Biological activity: blood circulation improver. Contact us for more information.
  • Ginseng 27-30%

    Product Ginseng 27-30%

    Indena SpA offers a wide range of pharmaceutical products which includes ginseng 27-30%. Botanical origin: panax ginseng c.a. meyer root. Biological activity: adaptogen, tonic. Contact us for more information.
  • Horse Chestnut Extract

    Product Horse Chestnut Extract

    Indena SpA offers a wide range of pharmaceutical products which includes horse chestnut extract. Botanical origin: aesculus hippocastanum l. seed. Biological activity: antioedema, venotropic. Contact us for more information.
  • Horsetail Extract

    Product Horsetail Extract

    Indena SpA offers a wide range of pharmaceutical products which includes horsetail extract. Botanical origin: equisetum arvense l. herb. Biological activity: hair / nail fragility reducer. Contact us for more information.
  • Lenvatinib mesylate
  • Myrtocyan®

    Product Myrtocyan®

    Indena SpA offers a wide range of pharmaceutical products which includes myrtocyan®. Botanical origin: vaccinium myrtillus l. fresh frozen fruit. Biological activity: ophtalmic, capillarotropic. Contact us for more information.
  • Paclitaxel

    Product Paclitaxel

    Indena SpA offers a wide range of pharmaceutical products which includes paclitaxel. Botanical origin: taxus media rehder root, leaf and twig. Biological activity: anti-mitotic / anticancer. 
  • Paclitaxel S

    Product Paclitaxel S

    Indena SpA offers a wide range of pharmaceutical products which includes paclitaxel s. Botanical origin: taxus baccata (l.) leaf and twig. Biological activity: anti-mitotic / anticancer. 
  • Prunuselect®

    Product Prunuselect®

    Indena SpA offers a wide range of pharmaceutical products which includes prunuselect®. Botanical origin: prunus africana (hook. f.) kalkm. bark. Biological activity: anti-bph. Contact us for more information.
  • Reserpine

    Product Reserpine

    Indena SpA offers a wide range of pharmaceutical products which includes reserpine. Botanical origin: rauvolfia vomitoria afz. root bark. Biological activity: antihypertensive. Contact us for more information.
  • Reserpine Micronized

    Product Reserpine Micronized

    Indena SpA offers a wide range of pharmaceutical products which includes reserpine micronized. Botanical origin: rauvolfia vomitoria afz. root bark. Biological activity: antihypertensive. Contact us for more information.

Indena S.P.A resources (3)

  • Video From the Rainforest to the Clinic. Turning a High-Potency Rare Natural Product Into an Anticancer API

    Natural products can be characterized by complex structure, limited availability, and exceptional potency, whose combination makes it challenging their development as API. Success requires integration of expertise in different areas, including the construction of a sustainable supply chain for the starting biomass, the capacity to manipulate high-potency products in a GMP environment, and the versatility to strategically complement isolation with semi-synthesis, total synthesis and biotechnology. In this context, mutual thrust between the service provider company and the drug candidate owner is critical, and the successful development of the anticancer drug tigilanol tiglate will give the opportunity to address these issues.
  • Whitepaper CDMO services

    We have a unique expertise in developing and manufacturing HPAPIs. The company is equipped with kilolabs (for clinical and small commercial batches) and large industrial suite for HPAPIs with an OEL>20 ng/m3.